SMITH LARRY J has a total of 27 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are LIN SHI-LUNG, RIBOZYME PHARM INC and HALO BIO RNAI THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 18 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | China | 1 | |
#6 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Machines | |
#5 | Computer technology | |
#6 | Audio-visual technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Sugars | |
#5 | Measuring microorganism processes | |
#6 | Unspecified technologies | |
#7 | Data recognition and presentation | |
#8 | Peptides | |
#9 | Television |
# | Name | Total Patents |
---|---|---|
#1 | Smith Larry J | 27 |
#2 | Gololobov Gennady | 1 |
#3 | Paul Sudhir | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015168661A1 | METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT | |
US2015025122A1 | Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro | |
US2015291957A1 | METHODS AND COMPOSITIONS TO PRODUCE ss-RNAi ACTIVITY WITH ENHANCED POTENCY | |
US2015010502A1 | Compositions and Methods for Suppressing Gene Expression of p53 and Clusterin | |
CN104271740A | Methods and compositions for modulating gene expression using components that self assemble in cells and produce RNAi activity | |
US2007297021A1 | Imaging scanner with multiple image fields | |
US7517644B1 | Method and compositions for cellular reprogramming |